Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Evelyne

Evelyne Aschaller, Munich DE

Patent application numberDescriptionPublished
20110293619CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY - The present invention relates to a bispecific single chain antibody molecule comprising a first binding domain capable of binding to an epitope of human and non-chimpanzee primate CD3 epsilon chain, wherein the epitope is part of an amino acid sequence comprised in the group consisting of SEQ ID NOs. 2, 4, 6, and 8, and a second binding domain capable of binding to prostate-specific membrane antigen (PSMA). The invention also provides nucleic acids encoding said bispecific single chain antibody molecule as well as vectors and host cells and a process for its production. The invention further relates to pharmaceutical compositions comprising said bispecific single chain antibody molecule and medical uses of said bispecific single chain anti-body molecule.12-01-2011

Evelyne Bachere, Clapiers FR

Patent application numberDescriptionPublished
20110045461USE OF ANTI-MICROBIAL PEPTIDES AS BACTERIAL INFECTION RESISTANCE MARKERS IN PENAEOID SHRIMP - The present invention relates to the use of transcripts of genes encoding antimicrobial peptides, for evaluating the resistance of penaeid shrimp, in particular of the species 02-24-2011

Evelyne Chataignier, Saint Medard En Jalles FR

Patent application numberDescriptionPublished
20120135223METHOD FOR DETACHABLE GLUING FOR POROUS MATERIALS - A method for detachably gluing at least one porous substrate to another material using at least one layer of a detachable adhesive comprising an ungluing admixture adapted for generating gases which, by gas expansion or gas migration towards at least one of the interfaces of the detachable adhesive layer, weakens the adhesive bond when heated by a detaching control, the aforementioned method including, before gluing, applying a metal sealing coating onto at least one of the substrates.05-31-2012

Evelyne Chaubert, San Francisco, CA US

Patent application numberDescriptionPublished
20080260210TEXT CAPTURE AND PRESENTATION DEVICE - Embodiments of the invention provide devices and methods for capturing text found in a variety of sources and transforming it into a different user-accessible formats or medium. For example, the device can capture text from a magazine and provide it to the user as spoken words through headphones or speakers. Such devices are useful for individuals such as those having reading difficulties (such as dyslexia), blindness, and other visual impairments arising from diabetic retinopathy, cataracts, age-related macular degeneration (AMD), and glaucoma.10-23-2008
20100239112TOOL FOR INSERTION AND REMOVAL OF IN-CANAL HEARING DEVICES - Methods, tools, and methods of manufacturing said tools are provided for inserting a hearing device deeply into the ear canal of a user and adjusting its medial-lateral position therein. The provided tools comprise a shaft. A distal end of the shaft can be coupled to the hearing device. The shaft is flexible to facilitate its insertion into the tortuous ear canal and minimize injurious contact with the ear canal. The length of the shaft can be adjusted to adjust the depth of insertion of the shaft into the ear canal, customizing the tool for an individual user. Medial advancement of the shaft into the ear canal is limited by a base, side extension, or mold coupled to a proximal portion of the shaft or other proximal part of the tool.09-23-2010

Evelyne Hutet, Plérin FR

Patent application numberDescriptionPublished
20100166791CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD) - The genome sequences and the nucleotide sequences coding for the PWD circovirus polypeptides, such as the circovirus structural and non-structural polypeptides, vectors including the sequences, and cells and animals transformed by the vectors are provided. Methods for detecting the nucleic acids or polypeptides, and kits for diagnosing infection by a PWD circovirus, also are provided. Method for selecting compounds capable of modulating the viral infection is further provided. Pharmaceutical, including vaccines, compositions for preventing and/or treating viral infections caused by PWD circovirus and the use of vectors for preventing and/or treating diseases also are provided.07-01-2010
20100189734CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD) - The genome sequences and the nucleotide sequences coding for the PWD circovirus polypeptides, such as the circovirus structural and non-structural polypeptides, vectors including the sequences, and cells and animals transformed by the vectors are provided. Methods for detecting the nucleic acids or polypeptides, and kits for diagnosing infection by a PWD circovirus, also are provided. Method for selecting compounds capable of modulating the viral infection are further provided. Pharmaceutical, including vaccine, compositions for preventing and/or treating viral infections caused by PWD circovirus and the use of vectors for preventing and/or treating diseases also are provided.07-29-2010

Evelyne Israel-Assayag, Quebec CA

Patent application numberDescriptionPublished
20080221085Nicotinic Receptor Agonists for the Treatment of Inflammatory Diseases - Nicotine receptor agonists or analogs or derivatives thereof for treating inflammatory pulmonary diseases, and pharmaceutical compositions including nicotine receptor agonists or analogs or derivatives thereof. Compounds of formula wherein R1, R2, Xa and Ya are as defined herein are also provided.09-11-2008

Evelyne Israel-Assayag, Sainte-Foy CA

Patent application numberDescriptionPublished
20100227871NICOTINIC RECEPTOR AGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES - This invention relates to the use of nicotine receptor agonists for treating inflammatory diseases, including a variety of pulmonary diseases. Such agonists have fewer side effects than other anti-inflammatory drugs, such as steroids. Moreover, these agonists can be used alone or in combination with other anti-inflammatory drugs to alleviate pulmonary diseases.09-09-2010
20110245270NICOTINIC RECEPTOR AGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES - Use of nicotine receptor agonists for treating inflammatory diseases, including a variety of pulmonary diseases. Such agonists have fewer side effects than other anti-inflammatory drugs, such as steroids. Moreover, these agonists can be used alone or in combination with other anti-inflammatory drugs to alleviate pulmonary diseases. For example, a method of treating pulmonary inflammation of an inflammatory disease selected from the group of asthma, interstitial pulmonary fibrosis (IPF), sarcoidosis, hypersensitivity pneumonitis (HP), and bronchiolitis obliterans with organizing pneumonitis (BOOP) in an animal in need thereof having said inflammation, including administering orally or by inhalation to said animal a nicotinic receptor agonist.10-06-2011
20110301152NICOTINIC RECEPTOR AGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES - Nicotine receptor agonists or analogs or derivatives thereof for treating inflammatory pulmonary diseases, and pharmaceutical compositions including nicotine receptor agonists or analogs or derivatives thereof. Compounds of formula wherein R1, R2, Xa and Ya are as defined herein are also provided.12-08-2011
20120022049NICOTINIC RECEPTOR AGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES - Nicotine receptor agonists or analogs or derivatives thereof for treating inflammatory pulmonary diseases, and pharmaceutical compositions including nicotine receptor agonists or analogs or derivatives thereof. Compounds of formula wherein R1, R2, Xa and Ya are as defined herein are also provided.01-26-2012

Patent applications by Evelyne Israel-Assayag, Sainte-Foy CA

Evelyne Israël-Assayag, Quebec CA

Patent application numberDescriptionPublished
20120093791STIMULATION OF INNATE IMMUNITY WITH AN ANTIGEN FROM BACTERIAL ORIGIN - There is provided a method of attenuating a respiratory infection in a subject, use of a composition for the manufacture of a medicament and a composition for treating respiratory infections comprising a preparation of 04-19-2012

Evelyne Jacquemyns, Sint-Martens-Latem BE

Patent application numberDescriptionPublished
20100192375METHOD FOR PRODUCING A DENTIST TOOL - Method for producing a dentist tool formed by an overlay to be used by a dentist in removing tooth structure, said method comprising the steps of: acquiring three-dimensional data relating to a shape of a tooth and at least a part of a neighbouring tooth; 08-05-2010

Evelyne Jacquemyns, Sint-Martens-Letem BE

Patent application numberDescriptionPublished
20100196842METHOD FOR PRODUCING A DENTIST TOOL - Method for producing a dentist tool formed by an overlay to be used by a dentist in removing tooth structure, said method comprising the steps of: 08-05-2010

Evelyne Janzek-Hawlat, Wien AT

Patent application numberDescriptionPublished
20110033524TREATMENT OF TUMORS - The invention provides for innovative improvements in tumour therapy, particularly therapies which are conducted using endogenous substances and which have no or only mild side-effects. Accordingly the present invention relates to methods of treating or preventing tumor diseases other than lung cancer comprising administering a polypeptide with an angiotensin-converting-enzyme-2 (ACE2) activity.02-10-2011

Evelyne Janzek-Hawlat, Vienna AT

Patent application numberDescriptionPublished
20100261214Method for Determining ACE2 Activity - The present invention relates to a method of determining ACE2 activity, comprising the following steps: providing ACE2-binding units immobilized on a solid carrier and specific for a part of ACE2 which is not involved in the catalytic activity of ACE2; contacting the immobilized ACE2-binding units with a sample which potentially includes the ACE2, wherein the ACE2 is bound by the ACE2-binding unit; removing the non-binding portions of the sample from the ACE2 bound to the ACE2-binding units; adding a substrate of the ACE2 which is reacted by the ACE2 activity, with the reaction providing a signal; and measuring the change in the signal during a specific period of time, wherein the change can be correlated with the ACE2 activity.10-14-2010
20100310546ACE2 Polypeptide - The present invention relates to recombinant ACE2 polypeptide, where the ACE2 polypeptide is present as a dimer. The dimer is formed specifically from glycosylated monomers and is used for producing pharmaceutical products with an extended half-life.12-09-2010

Evelyne Jouvin-Marche, Meylan FR

Patent application numberDescriptionPublished
20080286777Method of Determining the Diversity of T Lymphocytes in a Biological Sample - The invention relates to the field comprising the diagnosis of possible immune system disorders and the analysis of immune responses. In particular, the invention relates to a method of determining the diversity of T lymphocytes in a biological sample, based on the molecular analysis of the structure of the junctions resulting from the recombination rearrangement V(D)J of element δRec-1 with an AJ gene. More specifically, the invention relates to a method of analyzing the combinatorial diversity and/or the junctional diversity of the excision circles (TREC) resulting from the rearrangement of δRec-1, in order to determine the heterogeneity of a given population of T lymphocytes.11-20-2008

Evelyne Lollichon, Chantilly, VA US

Patent application numberDescriptionPublished
20090254393BILLING, DOCKETING AND DOCUMENT MANAGEMENT - A server and distributed client docketing management system includes a first client computer module on a first client computer that collects administrative information to collect a docketing template for a specified activity. A second client computer module on a second client computer applies the docketing template to a specified file upon determination of occurrence of the specified activity. A third client computer module on a third client computer presents docket entries of the docketing template on a docket for a day on which the docket entries require answers. A fourth client computer module on a fourth client computer presents proposed answers to the docket entries of the docketing template on the docket for the day on which the docket entries require answers.10-08-2009

Evelyne Nguyên, Sint-Lambrechts-Woluwe BE

Patent application numberDescriptionPublished
20110017101Process for Producing a Granular Material - The present invention relates to a process for producing a granular material 01-27-2011
20110023659Process for Preparing a Foaming Slag Former, Product and Use Thereof - The present invention relates to a process for preparing a foaming slag former 02-03-2011

Evelyne Nguyên, Sint-Lambrechts-Woluwe BE

Patent application numberDescriptionPublished
20100170421Process for Preparing a Filler for Asphalt or Concrete Starting From a Slag Material - The present invention relates to a process for preparing, starting from a slag material, a filler for construction materials which contain bitumen or a hydraulic binding agent. The slag used to prepare the filler contains γ-dicalcium silicate. The process comprises the step of removing from the slag material a finer fraction formed by particles of a size between 0 and at least 0.75 mm so as to reduce the γ-dicalcium silicate content of the slag material; and the step of finely milling at least a portion of the remaining coarser fraction of the slag to obtain the filler. The invention also relates to the obtained filler, to the use thereof for preparing construction materials and to concrete or mortar compositions and asphalt compositions containing the filler. By removing the finer fraction from the slag material, a filler is obtained which has a considerably lower water content so that it becomes suitable for use in asphalt or concrete or mortar compositions, in particular in self-compacting concrete compositions.07-08-2010
20110017101Process for Producing a Granular Material - The present invention relates to a process for producing a granular material 01-27-2011
20110023659Process for Preparing a Foaming Slag Former, Product and Use Thereof - The present invention relates to a process for preparing a foaming slag former 02-03-2011

Evelyne Tzoukermann, Silver Spring, MD US

Patent application numberDescriptionPublished
20100158470IDENTIFICATION OF SEGMENTS WITHIN AUDIO, VIDEO, AND MULTIMEDIA ITEMS - The invention pertains to methods, systems, and apparatus for identifying segments within a media item, the media segment including at least one of audio content and video content, comprising segmenting the media item into a plurality of segments as a function of subject matter, storing data identifying each segment and its subject matter, and organizing each segment within an ontology based on its subject matter.06-24-2010
20100161580METHOD AND APPARATUS FOR ORGANIZING SEGMENTS OF MEDIA ASSETS AND DETERMINING RELEVANCE OF SEGMENTS TO A QUERY - The invention pertains to methods, systems, and apparatus for identifying media items relevant to a selected subject matter, the method comprising determining the subject matter of a first media item, the first media item comprising at least one of audio content and video content, determining the classification within an ontology of the subject matter of the first media item, analyzing the ontology to identify other subject matter related to the subject matter of the first media item, and performing a search for other media items relevant to the subject matter of the first media item as a function of at least the other related subject matter according to the ontology.06-24-2010
20110211812Program Segmentation of Linear Transmission - Content streams may be segmented to provide automatic extraction and storage of content items without intervening commercials or other unrelated content. These content items may then be stored in a database and made accessible to subscribers through, for example, an on-demand service. Automatic segmentation may include the identification of program boundaries, segmentation of a content stream based on the boundaries and the subsequent classification of the segments into content types. For example, audio and video duplication detection may be used to identify commercials since commercials tend to repeat frequently over a relatively short amount of time. A system may further identify an end of program indicator in a video stream to determine when a program ends. Accordingly, if a program ends after a scheduled end time, a recording device (e.g., the program is being recorded) may automatically extend the recording time to capture the entire program.09-01-2011

Evelyne Vallat-Sauvain, Chezard St. Martin CH

Patent application numberDescriptionPublished
20100313932METHOD FOR OBTAINING HIGH PERFORMANCE THIN FILM DEVICES DEPOSITED ON HIGHLY TEXTURED SUBSTRATES - The present invention provides an improved thin film solar cell, wherein at least one additional resistive transparent conductive oxide (TCO) layer is incorporated into the solar cell. The additional resistive TCO electrically separates the conductive TCO layers acting as electrodes of such a cell and thus decreases or prevents performance losses. Furthermore, methods for the production of such solar cells are disclosed.12-16-2010
20110186127METHOD FOR DEPOSITING AN AMORPHOUS SILICON FILM FOR PHOTOVOLTAIC DEVICES WITH REDUCED LIGHT-INDUCED DEGRADATION FOR IMPROVED STABILIZED PERFORMANCE - A thin film photovoltaic device on a substrate is being realized by a method for manufacturing a p-i-n junction semiconductor layer stack with a p-type microcrystalline silicon layer, a p-type amorphous silicon layer, a buffer silicon layer comprising preferably intrinsic amorphous silicon, an intrinsic type amorphous silicon layer, and an n-type silicon layer over the intrinsic type amorphous silicon layer.08-04-2011
20110240107LARGE-AREA THIN-FILM-SILICON PHOTOVOLTAIC MODULES - Micromorph tandem cells with stabilized efficiencies of 11.0% have been achieved on as-grown LPCVD ZnO front TCO at bottom cell thickness of just 1.3 μm in combination with an antireflection concept. Applying an advanced LPCVD ZnO front TCO stabilized tandem cells of 10.6% have been realized at a bottom cell thickness of only 0.8 μm. Implementing intermediate reflectors in Micromorph tandem cell devices allow for, compared to commercial SnO10-06-2011